Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2023-06-05 Sale |
2023-06-07 7:15 pm |
Jazz Pharmaceuticals plc | JAZZ | Sablich Kim EVP, GM of U.S. |
2,082 | $129.73 | $270,098 | 28,478 (Direct) |
View |
2023-03-08 Sale |
2023-03-10 6:10 pm |
Jazz Pharmaceuticals plc | JAZZ | Sablich Kim EVP, GM of U.S., Commercial Ma |
3,013 | $139.74 | $421,043 | 30,560 (Direct) |
View |
2022-06-06 Sale |
2022-06-08 4:56 pm |
Jazz Pharmaceuticals plc | JAZZ | Sablich Kim EVP & GM, North America |
3,829 | $151.45 | $579,898 | 24,754 (Direct) |
View |
2021-11-11 Sale |
2021-11-15 7:30 pm |
Jazz Pharmaceuticals plc | JAZZ | Sablich Kim EVP & GM, North America |
2,748 | $135.01 | $371,000 | 21,135 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2023-03-05 Tax Withholding |
2023-03-07 8:50 pm |
N/A N/A |
Jazz Pharmaceuticals plc | JAZZ | Sablich Kim EVP, GM of U.S., Commercial Ma |
1,610 | $142.78 | 33,573 (Direct) |
View |
2023-03-03 Option Award |
2023-03-07 8:50 pm |
N/A N/A |
Jazz Pharmaceuticals plc | JAZZ | Sablich Kim EVP, GM of U.S., Commercial Ma |
10,429 | $0 | 33,573 (Direct) |
View |
2023-03-01 Option Award |
2023-03-03 8:50 pm |
N/A 2033-02-28 |
Eiger BioPharmaceuticals Inc. | EIGR | Sablich Kim Director |
28,000 | $0 | 28,000 (Direct) |
View |
2022-06-06 Tax Withholding |
2022-06-08 4:56 pm |
N/A N/A |
Jazz Pharmaceuticals plc | JAZZ | Sablich Kim EVP & GM, North America |
1,759 | $149.25 | 24,754 (Direct) |
View |
2022-03-11 Option Award |
2022-03-11 9:06 pm |
N/A 2032-03-10 |
Eiger BioPharmaceuticals Inc. | EIGR | Sablich Kim Director |
18,000 | $0 | 18,000 (Direct) |
View |
2022-03-05 Tax Withholding |
2022-03-09 6:05 pm |
N/A N/A |
Jazz Pharmaceuticals plc | JAZZ | Sablich Kim EVP & GM, North America |
746 | $153.96 | 30,342 (Direct) |
View |
2022-03-03 Option Award |
2022-03-09 6:05 pm |
N/A N/A |
Jazz Pharmaceuticals plc | JAZZ | Sablich Kim EVP & GM, North America |
9,953 | $0 | 30,342 (Direct) |
View |
2021-06-05 Tax Withholding |
2021-06-09 6:55 pm |
N/A N/A |
Jazz Pharmaceuticals plc | JAZZ | Sablich Kim EVP & GM, North America |
1,452 | $176.47 | 23,883 (Direct) |
View |
2021-04-23 Option Award |
2021-04-23 5:35 pm |
N/A 2031-04-22 |
Eiger BioPharmaceuticals Inc. | EIGR | Sablich Kim Director |
25,000 | $0 | 25,000 (Direct) |
View |
2021-02-25 Option Award |
2021-03-01 6:17 pm |
N/A N/A |
Jazz Pharmaceuticals plc | JAZZ | Sablich Kim EVP & GM, North America |
8,535 | $0 | 25,335 (Direct) |
View |
2020-08-06 Option Award |
2020-08-07 7:26 pm |
N/A 2030-08-05 |
Jazz Pharmaceuticals plc | JAZZ | Sablich Kim EVP & GM, North America |
58,800 | $0 | 58,800 (Direct) |
View |